MIRA INFORM REPORT

 

 

Report Date :

26.12.2014

 

IDENTIFICATION DETAILS

 

Name :

AMNEAL LIFE SCIENCES PRIVATE LIMITED

 

 

Registered Office :

882/1-871, Village Rajoda, Near Hotel Kankavati, Bavla - 382220, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

31.03.2008

 

 

Com. Reg. No.:

04-053430

 

 

Capital Investment / Paid-up Capital :

Rs. 586.794 Millions

 

 

CIN No.:

[Company Identification No.]

U73100GJ2008PTC053430

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMA07921E

 

 

PAN No.:

[Permanent Account No.]

AAGCA9685C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Bulk Drugs.

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (29)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Maximum Credit Limit :

USD 2060000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of Amneal Pharmaceuticals Company India Limited.

 

It is an established company having moderate track record.

 

Even though the company was incorporated during the year 2008, the company commenced its commercial operations from FY 2014.

 

The company has achieved a sizable turnover and profit from its first year of operation.

 

However, reserves level of the company is low. Borrowing of the company has also increased during 2014.

 

Trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Ms. Pushpa Joshi

Designation :

Company Secretary

Contact No.:

91-79-67778300

Date :

23.12.2014

 

 

LOCATIONS

 

Registered Office :

882/1-871, Village Rajoda, Near Hotel Kankavati, Bavla - 382220, Gujarat, India

Tel. No.:

91-2714-304700/ 671500

Mobile No.:

91-8511174070 [Mr. Harshal]

Fax No.:

91-2714-304704

E-Mail :

pushpaj@amnealindia.com

Website :

http://www.amneal.com

Location :

Owned

 

 

Factory :

Plot No. 15, 16, 17, Pharmez (Special Economic Zone – SEZ), Sarkhej Bavla Highway, Matoda, Sanand, Ahmedabad – 382213, Gujarat, India

 

 

DIRECTORS

 

AS ON 30.09.2014

 

Name :

Mr. Suresh Punambhai Patel

Designation :

Director

Address :

Block No. Shri Somnathnagar CHS Limited, B/H Sanghvi School, Navrangpura Road, Wadaj, Ahmedabad – 380013, Gujarat, India

Date of Birth/Age :

15.03.1961

Date of Appointment :

31.03.2008

PAN No.:

ACRPP4822E

DIN No.:

01856345

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ2006PTC048109

AMNEAL PHARMACEUTICALS COMPANY (INDIA) PRIVATE LIMITED

Whole-time director

01/10/2011

07/04/2006

Active

NO

2

U73100GJ2008PTC053430

AMNEAL LIFE SCIENCES PRIVATE LIMITED

Director

31/03/2008

31/03/2008

Active

NO

3

U24233GJ2008PTC068526

RAKS PHARMA PRIVATE LIMITED

Director

30/09/2011

30/07/2010

Active

NO

4

U24230TG1998PTC030477

EPSILON PHARMACEUTICALS PRIVATE LIMITED

Additional director

01/12/2014

01/12/2014

Active

NO

 

 

Name :

Mr. Kanubhai Punambhai Patel

Designation :

Director

Address :

22, Ramyakunj Society, Galaxi Cinema, Naroda, Ahmedabad – 382325, Gujarat, India

Date of Birth/Age :

31.08.1942

Date of Appointment :

31.03.2008

DIN No.:

01883090

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ2006PTC048109

AMNEAL PHARMACEUTICALS COMPANY (INDIA) PRIVATE LIMITED

Director

17/11/2007

17/11/2007

Active

NO

2

U73100GJ2008PTC053430

AMNEAL LIFE SCIENCES PRIVATE LIMITED

Director

31/03/2008

31/03/2008

Active

NO

 

 

Name :

Mr. Nikunj Bansibhai Patel

Designation :

Director

Address :

A/29/A, Karmacharinagar Society, Part I, Opposite Alkapuri Society, Ghatlodia, Ahmedabad – 380061, Gujarat, India

Date of Birth/Age :

04.11.1975

Date of Appointment :

30.09.2013

PAN No.:

ALJPP2060M

DIN No.:

02790495

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24231GJ2006PTC048109

AMNEAL PHARMACEUTICALS COMPANY (INDIA) PRIVATE LIMITED

Whole-time director

01/10/2011

01/09/2009

Active

NO

2

U24233GJ2008PTC068526

RAKS PHARMA PRIVATE LIMITED

Director

30/09/2011

30/07/2010

Active

NO

3

U73100GJ2008PTC053430

AMNEAL LIFE SCIENCES PRIVATE LIMITED

Director

30/09/2013

23/09/2013

Active

NO

4

U24230TG1998PTC030477

EPSILON PHARMACEUTICALS PRIVATE LIMITED

Additional director

01/12/2014

01/12/2014

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Ms. Pushpa Joshi

Designation :

Company Secretary

Address :

A-505, Smarana Apartments, Near Torrent Power Zonal Office, Bakeri City, Vejalpur, Ahmedabad – 382220, Gujarat, India

Date of Birth/Age :

03.03.1986

Date of Appointment :

09.04.2012

PAN No.:

AXSPP6822A

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2014

 

Names of Shareholders

No. of Shares

 

Percentage of Holding

Amneal Singapore Private Limited, Singapore

77040282

94.11

Kanu Patel

2152857

2.63

Suresh Patel

445557

0.54

Nikunj Patel

2073000

2.53

Pankil Patel

150000

0.18

 

 

 

Total

 

81861696

100.00

 

 

 

 

AS ON 30.09.2014

 

Equity Share Breakup

Percentage of Holding

Category

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

94.11

Directors or relatives of directors

5.89

 

 

Total

 

100\.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Bulk Drugs.

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

--

 

 

Imports :

--

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

Customers :

Wholesalers, Retailers and Manufacturer

 

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

Bank Name:

Not Divulged

Branch:

Not Divulged

Person Name (with Designation):

Not Divulged

Contact Number:

Not Divulged

Name of Account Holder:

Not Divulged

Account Number:

Not Divulged

Account Since (Date/ Year of A/c Opening):

Not Divulged

Average Balance Maintained (Optional):

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan):

Not Divulged

Account Operation:

Not Divulged

Remarks: Not Divulged

 

·         Bank of Baroda

Shapath-III, Ground Floor, Near GNFC Info Tower, Bodakdev, Ahmedabad - 380054, Gujarat, India

 

 

Facilities :

 

SECURED LOANS

31.03.2014

(Rs. In Millions)

31.03.2013

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Term loans from banks

1595.049

859.090

 

 

 

Total

 

1595.049

859.090

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S.V. Ghatalia and Associates LLP

Chartered Accountants

Address :

2nd Floor, Shivalik Ishaan, Near C N Vidhyalaya, Ambawadi, Ahmedabad, Gujarat, India

Income-tax PAN of auditor or auditor's firm :

ACHFS9181P

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

·         Amneal Pharmaceuticals Company (India) Private Limited [U24231GJ2006PTC048109]

·         Amneal Pharmaceuticals LLC

 

 

Associate company :

Amneal Pharma Investment Holdings

 

 

Holding company :

Amneal Singapore Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

90,000,000

Equity Shares

Rs. 10/- each

Rs. 900.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

81,861,696

Equity Shares

Rs. 10/- each

Rs. 818.617 Millions

 

 

 

 

 

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

80,000,000

Equity Shares

Rs. 10/- each

Rs. 800.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

58,679,433

Equity Shares

Rs. 10/- each

Rs. 586.794 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

586.794

271.246

217.068

(b) Reserves & Surplus

73.836

(6.289)

0.000

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

61.798

0.000

0.000

Total Shareholders’ Funds (1) + (2)

722.428

264.957

217.068

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

1595.049

859.090

621.594

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

2.939

0.242

0.000

Total Non-current Liabilities (3)

1597.988

859.332

621.594

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

50.970

0.000

0.000

(c) Other current liabilities

194.623

81.017

10.812

(d) Short-term provisions

8.226

4.500

0.415

Total Current Liabilities (4)

253.819

85.517

11.227

 

 

 

 

TOTAL

2574.235

1209.806

849.889

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1202.246

95.894

92.891

(ii) Intangible Assets

1.197

0.000

0.028

(iii) Capital work-in-progress

675.288

811.685

130.887

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

287.421

160.587

32.833

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

2166.152

1068.166

256.639

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

120.830

0.000

350.044

(b) Inventories

133.413

0.000

0.000

(c) Trade receivables

98.362

0.000

0.000

(d) Cash and cash equivalents

36.435

131.407

242.189

(e) Short-term loans and advances

18.100

9.566

0.460

(f) Other current assets

0.943

0.667

0.557

Total Current Assets

408.083

141.640

593.250

 

 

 

 

TOTAL

2574.235

1209.806

849.889

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

 

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Income

 

505.167

0.000

 

 

Other Income

 

2.040

0.442

 

 

TOTAL                                    

 

507.207

0.442

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                    

 

467.825

6.731

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX

 

39.382

(6.289)

 

 

 

 

 

Less

TAX                                                                 

 

7.814

0.000

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX

 

31.568

(6.289)

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

 

0.54

(0.23)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

6.25

0.00

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.07

(1.58)

NA

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.05

(0.02)

NA

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

2.21

3.24

2.86

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.61

1.66

52.84

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particulars

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

217.068

271.246

586.794

Reserves & Surplus

0.000

(6.289)

73.836

Share Application money pending allotment

0.000

0.000

61.798

Net worth

217.068

264.957

722.428

 

 

 

 

Long-term borrowings

621.594

859.090

1595.049

Short term borrowings

0.000

0.000

0.000

Total borrowings

621.594

859.090

1595.049

Debt/Equity ratio

2.864

3.242

2.208

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

Sales

0.000

505.167

 

 

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

Sales

0.000

505.167

Profit/ (Loss)

(6.289)

31.568

 

 

6.25%

 

 

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last two years

Yes

12]

Profitability for last two years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10333830

04/01/2014 *

2,024,500,000.00

BANK OF BARODA

SHAPATH-III, GROUND FLOOR, NR. GNFC INFO TOWER, 
BODAKDEV, AHMEDABAD, GUJARAT - 380054, INDIA

B93501203

 

* Date of charge modification

 

 

CORPORATE INFORMATION

 

The company domiciled in India and incorporated under the provisions of the Companies Act, 1956. The company is in the process of setting up of the new manufacturing facility for injectible and oral solid drugs and is also engaged in carrying out scientific research and development by undertaking pharmaceuticals, research, Novel Drug Delivery Systems, research (NODS), and analytical testing and to market this research and development, mainly for the export purpose for the US and European markets as well as other markets.

 

 

PERFORMANCE REVIEW

 

During the year the company has initiated commercial activities and it’s Sales of Services for the year financial year 2013-14 Rs. 505.167 Millions.

 

 

FIXED ASSETS:

 

·         Land

·         Buildings

·         Plant and equipment

·         Furniture and fixtures

·         Vehicles

·         Office equipment

·         Computer software

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 63.45

UK Pound

1

Rs. 98.88

Euro

1

Rs. 77.62

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

29

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.